LINFOMAS Y TRASPLANTES
Dokuz Eylül University
Esmirna, TurquíaPublicaciones en colaboración con investigadores/as de Dokuz Eylül University (3)
2022
2019
-
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
The Lancet Haematology, Vol. 6, Núm. 2, pp. e67-e78